The pilot project of the National Cancer Network in Poland: Assessment of the functioning of the National Cancer Network and results from quality indicators for lung cancer (2019-2021).


Journal

BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800

Informations de publication

Date de publication:
31 Aug 2022
Historique:
received: 28 06 2022
accepted: 17 08 2022
entrez: 31 8 2022
pubmed: 1 9 2022
medline: 8 9 2022
Statut: epublish

Résumé

This analysis presents the outcomes of the operations of the National Cancer Network (NCN) pilot project in Lower Silesian Voivodeship, Poland, for lung cancer for the period of 2019-2021. The results concerning measures of the quality of medical processes were analysed. Twenty-one measures used to gauge the quality of oncological care for lung cancer were assessed. Data collection and processing for the purpose of calculating the measures were carried out as part of the NCN pilot project based on the Regulation of the Ministry of Health enacted on 13 December 2018. The measures were calculated at the Voivodeship Coordination Center, and the data were derived from the centres included in the network in the area of the analysed voivodeship. A total of 3,638 patients diagnosed with lung cancer were enrolled in the NCN pilot program during the analysed period. For 3 measures, out of 21, target values were obtained. For 2 measures, the values differed significantly from the assumed target value. In our opinion, the NCN pilot study, as a test of the network's functioning, meets the assumed goal. The NCN assessment is based on, inter alia, analysis of the outcomes of oncological quality of care measures for lung cancer, and facilitates monitoring of the quality of medical services provided and the identification of areas for improvement. In addition, the pilot program, which will last until the end of 2022, will allow for further in-depth analysis regarding the network's limitations before implementing the system on a national scale in Poland. This will be the subject of further investigation.

Sections du résumé

BACKGROUND BACKGROUND
This analysis presents the outcomes of the operations of the National Cancer Network (NCN) pilot project in Lower Silesian Voivodeship, Poland, for lung cancer for the period of 2019-2021. The results concerning measures of the quality of medical processes were analysed.
METHODS METHODS
Twenty-one measures used to gauge the quality of oncological care for lung cancer were assessed. Data collection and processing for the purpose of calculating the measures were carried out as part of the NCN pilot project based on the Regulation of the Ministry of Health enacted on 13 December 2018. The measures were calculated at the Voivodeship Coordination Center, and the data were derived from the centres included in the network in the area of the analysed voivodeship.
RESULTS RESULTS
A total of 3,638 patients diagnosed with lung cancer were enrolled in the NCN pilot program during the analysed period. For 3 measures, out of 21, target values were obtained. For 2 measures, the values differed significantly from the assumed target value.
CONCLUSION CONCLUSIONS
In our opinion, the NCN pilot study, as a test of the network's functioning, meets the assumed goal. The NCN assessment is based on, inter alia, analysis of the outcomes of oncological quality of care measures for lung cancer, and facilitates monitoring of the quality of medical services provided and the identification of areas for improvement. In addition, the pilot program, which will last until the end of 2022, will allow for further in-depth analysis regarding the network's limitations before implementing the system on a national scale in Poland. This will be the subject of further investigation.

Identifiants

pubmed: 36045330
doi: 10.1186/s12885-022-10020-9
pii: 10.1186/s12885-022-10020-9
pmc: PMC9434856
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

939

Subventions

Organisme : Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu
ID : SUBZ.C280.22.001

Informations de copyright

© 2022. The Author(s).

Références

Clin Oncol (R Coll Radiol). 2017 Nov;29(11):e177-e185
pubmed: 28780009
Br J Cancer. 2020 Dec;123(Suppl 1):3-9
pubmed: 33293670
Transl Lung Cancer Res. 2015 Aug;4(4):424-31
pubmed: 26380183
BMC Cancer. 2012 Jul 19;12:297
pubmed: 22813349
BMC Cancer. 2020 Apr 19;20(1):334
pubmed: 32306924
BMC Cancer. 2021 Nov 20;21(1):1252
pubmed: 34800990
J Multidiscip Healthc. 2016 Mar 30;9:137-44
pubmed: 27099511
J Thorac Oncol. 2021 May;16(5):860-867
pubmed: 33476803
Pract Radiat Oncol. 2015 May-Jun;5(3):e245-e253
pubmed: 25413398
N Engl J Med. 2001 Jul 19;345(3):181-8
pubmed: 11463014
J Thorac Oncol. 2013 Oct;8(10):1238-47
pubmed: 24457234
N Engl J Med. 2018 Dec 13;379(24):2342-2350
pubmed: 30280658
JCO Oncol Pract. 2020 Feb;16(2):e211-e220
pubmed: 31855497
BMC Cancer. 2019 Nov 12;19(1):1099
pubmed: 31718596

Auteurs

Łukasz Trembecki (Ł)

Department of Oncology, Wroclaw Medical University, pl. L. Hirszfelda 12, 53-413, Wroclaw, Poland. trembecki.lukasz@dco.com.pl.
Department of Radiotherapy, Lower Silesian Oncology, Pulmonology and Haematology Center, Pl. L, Hirszfelda 12, Wroclaw, 53-413, Poland. trembecki.lukasz@dco.com.pl.

Aleksandra Sztuder (A)

Department of Oncology, Wroclaw Medical University, pl. L. Hirszfelda 12, 53-413, Wroclaw, Poland.
Department of Radiotherapy, Lower Silesian Oncology, Pulmonology and Haematology Center, Pl. L, Hirszfelda 12, Wroclaw, 53-413, Poland.

Izabella Dębicka (I)

Department of Chemotherapy, Lower Silesian Oncology, Pulmonology and Haematology Center, pl. L. Hirszfelda 12, Wroclaw, 53-413, Poland.

Rafał Matkowski (R)

Department of Oncology, Wroclaw Medical University, pl. L. Hirszfelda 12, 53-413, Wroclaw, Poland.
Breast Unit, Lower Silesian, Oncology, Pulmonology and Haematology Center,, Pl. L. Hirszfelda 12, Wroclaw, 53-413, Poland.

Adam Maciejczyk (A)

Department of Oncology, Wroclaw Medical University, pl. L. Hirszfelda 12, 53-413, Wroclaw, Poland.
Department of Radiotherapy, Lower Silesian Oncology, Pulmonology and Haematology Center, Pl. L, Hirszfelda 12, Wroclaw, 53-413, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH